Thus, the acute decline of circulating CD8+CD161+Vα7.2+ cells together with their strong activation in acute COVID-19 is in agreement with the suggested important antiviral role for MAITs against SARS-CoV-2 infection. The gene discussed is KLRB1; the disease is COVID-19.